OSL oncosil medical ltd

Ann: Appendix 4E Preliminary Financial Report, page-3

  1. 5 Posts.
    Revenues down 12.7%
    Consulting, finance and legal costs up $1m
    Net foreign exchange loss of $0.25m
    APAC and NZ gone.

    We're basically in September so Oncosil must have about $2.5m in cash at their current burn rate? Does that mean they are at risk of being delisted?

    Interestingly, APAC has a revenue of $15k... my guess is that is roughly what a single dose costs.

    Not looking good fellas.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.010(0.86%)
Mkt cap ! $21.74M
Open High Low Value Volume
$1.17 $1.17 $1.14 $80.47K 69.48K

Buyers (Bids)

No. Vol. Price($)
1 2150 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 7380 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.